Cargando…
Economic Evaluation in Stratified Medicine: Methodological Issues and Challenges
Background: Stratified Medicine (SM) is becoming a practical reality with the targeting of medicines by using a biomarker or genetic-based diagnostic to identify the eligible patient sub-population. Like any healthcare intervention, SM interventions have costs and consequences that must be considere...
Autores principales: | Fugel, Hans-Joerg, Nuijten, Mark, Postma, Maarten, Redekop, Ken |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861004/ https://www.ncbi.nlm.nih.gov/pubmed/27242524 http://dx.doi.org/10.3389/fphar.2016.00113 |
Ejemplares similares
-
Stratified Medicine and Reimbursement Issues
por: Fugel, Hans-Joerg, et al.
Publicado: (2012) -
An economic assessment of embryo diagnostics (Dx) - the costs of introducing non-invasive embryo diagnostics into IVF standard treatment practices
por: Fugel, Hans-Joerg, et al.
Publicado: (2014) -
Cost-Utility Analysis: Current Methodological Issues and Future Perspectives
por: Nuijten, Mark J. C., et al.
Publicado: (2011) -
Nutrition economic evaluation of a probiotic in the prevention of antibiotic-associated diarrhea
por: Lenoir-Wijnkoop, Irene, et al.
Publicado: (2014) -
Health economic evaluation of gene replacement therapies: methodological issues and recommendations
por: Aballéa, Samuel, et al.
Publicado: (2020)